iShares NASDAQ US Biotechnology UCITS ETF (LON:BTEK)
4.530
+0.014 (0.30%)
Apr 29, 2025, 8:35 AM BST
LON:BTEK Holdings List
As of Apr 24, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.97% |
2 | GILD | Gilead Sciences, Inc. | 8.12% |
3 | AMGN | Amgen Inc. | 7.94% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.03% |
5 | AZN | AstraZeneca PLC | 4.42% |
6 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.42% |
7 | SMMT | Summit Therapeutics Inc. | 2.95% |
8 | ARGX | argenx SE | 2.10% |
9 | BIIB | Biogen Inc. | 1.91% |
10 | SNY | Sanofi | 1.68% |
11 | RPRX | Royalty Pharma plc | 1.51% |
12 | UTHR | United Therapeutics Corporation | 1.45% |
13 | INSM | Insmed Incorporated | 1.36% |
14 | ILMN | Illumina, Inc. | 1.34% |
15 | BNTX | BioNTech SE | 1.31% |
16 | BMRN | BioMarin Pharmaceutical Inc. | 1.30% |
17 | INCY | Incyte Corporation | 1.24% |
18 | ONC | BeiGene, Ltd. | 1.17% |
19 | MRNA | Moderna, Inc. | 1.15% |
20 | NBIX | Neurocrine Biosciences, Inc. | 1.15% |
21 | EXEL | Exelixis, Inc. | 1.14% |
22 | ASND | Ascendis Pharma A/S | 1.06% |
23 | VTRS | Viatris Inc. | 1.05% |
24 | MEDP | Medpace Holdings, Inc. | 1.01% |
25 | TEM | Tempus AI, Inc. | 0.98% |
26 | ROIV | Roivant Sciences Ltd. | 0.86% |
27 | HALO | Halozyme Therapeutics, Inc. | 0.80% |
28 | RVMD | Revolution Medicines, Inc. | 0.78% |
29 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.77% |
30 | BBIO | BridgeBio Pharma, Inc. | 0.75% |
31 | JAZZ | Jazz Pharmaceuticals plc | 0.72% |
32 | SRPT | Sarepta Therapeutics, Inc. | 0.65% |
33 | GH | Guardant Health, Inc. | 0.64% |
34 | BPMC | Blueprint Medicines Corporation | 0.60% |
35 | ADMA | ADMA Biologics, Inc. | 0.58% |
36 | AXSM | Axsome Therapeutics, Inc. | 0.56% |
37 | VRNA | Verona Pharma plc | 0.56% |
38 | NUVL | Nuvalent, Inc. | 0.53% |
39 | KRYS | Krystal Biotech, Inc. | 0.53% |
40 | CYTK | Cytokinetics, Incorporated | 0.52% |
41 | IONS | Ionis Pharmaceuticals, Inc. | 0.51% |
42 | ALKS | Alkermes plc | 0.49% |
43 | PCVX | Vaxcyte, Inc. | 0.48% |
44 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.43% |
45 | PTCT | PTC Therapeutics, Inc. | 0.43% |
46 | RNA | Avidity Biosciences, Inc. | 0.41% |
47 | ACLX | Arcellx, Inc. | 0.38% |
48 | RARE | Ultragenyx Pharmaceutical Inc. | 0.38% |
49 | SWTX | SpringWorks Therapeutics, Inc. | 0.37% |
50 | CRSP | CRISPR Therapeutics AG | 0.37% |
As of Apr 24, 2025